259 related articles for article (PubMed ID: 31474169)
1. Statins and the potential for higher diabetes mellitus risk.
Yandrapalli S; Malik A; Guber K; Rochlani Y; Pemmasani G; Jasti M; Aronow WS
Expert Rev Clin Pharmacol; 2019 Sep; 12(9):825-830. PubMed ID: 31474169
[No Abstract] [Full Text] [Related]
2. Statins and Higher Diabetes Mellitus Risk: Incidence, Proposed Mechanisms, and Clinical Implications.
Guber K; Pemmasani G; Malik A; Aronow WS; Yandrapalli S; Frishman WH
Cardiol Rev; 2021 Nov-Dec 01; 29(6):314-322. PubMed ID: 32947479
[TBL] [Abstract][Full Text] [Related]
3. Statin-associated incident diabetes: a literature review.
Park ZH; Juska A; Dyakov D; Patel RV
Consult Pharm; 2014; 29(5):317-34. PubMed ID: 24849689
[TBL] [Abstract][Full Text] [Related]
4. Diabetogenic Action of Statins: Mechanisms.
Carmena R; Betteridge DJ
Curr Atheroscler Rep; 2019 Apr; 21(6):23. PubMed ID: 31037345
[TBL] [Abstract][Full Text] [Related]
5. Statin Therapy: Diabetes Mellitus Risk and Cardiovascular Benefit in Primary Prevention.
Porath A; Arbelle JE; Fund N; Cohen A; Mosseri M
Isr Med Assoc J; 2018 Aug; 20(8):480-485. PubMed ID: 30084572
[TBL] [Abstract][Full Text] [Related]
6. Statins and their increased risk of inducing diabetes.
Agouridis AP; Kostapanos MS; Elisaf MS
Expert Opin Drug Saf; 2015; 14(12):1835-44. PubMed ID: 26437128
[TBL] [Abstract][Full Text] [Related]
7. Risk of diabetes in patients treated with HMG-CoA reductase inhibitors.
Cho Y; Choe E; Lee YH; Seo JW; Choi Y; Yun Y; Wang HJ; Ahn CW; Cha BS; Lee HC; Kang ES
Metabolism; 2015 Apr; 64(4):482-8. PubMed ID: 25312577
[TBL] [Abstract][Full Text] [Related]
8. Incidence of statin use in older adults with and without cardiovascular disease and diabetes mellitus, January 2008- March 2018.
Panozzo CA; Curtis LH; Marshall J; Fine L; Wells BL; Brown JS; Haynes K; Pawloski PA; Hernandez AF; Malek S; Syat B; Platt R
PLoS One; 2019; 14(12):e0223515. PubMed ID: 31805056
[TBL] [Abstract][Full Text] [Related]
9. Hypolipidemic Drugs and Diabetes Mellitus-Mechanisms and Data From Genetic Trials.
Filippatos TD; Panagiotopoulou T; Tzavella E; Elisaf MS
J Cardiovasc Pharmacol Ther; 2018 May; 23(3):187-191. PubMed ID: 29409336
[TBL] [Abstract][Full Text] [Related]
10. Balancing Primary Prevention and Statin-Induced Diabetes Mellitus Prevention.
Rochlani Y; Kattoor AJ; Pothineni NV; Palagiri RDR; Romeo F; Mehta JL
Am J Cardiol; 2017 Oct; 120(7):1122-1128. PubMed ID: 28797470
[TBL] [Abstract][Full Text] [Related]
11. The controversies of statin therapy: weighing the evidence.
Jukema JW; Cannon CP; de Craen AJ; Westendorp RG; Trompet S
J Am Coll Cardiol; 2012 Sep; 60(10):875-81. PubMed ID: 22902202
[TBL] [Abstract][Full Text] [Related]
12. [STATINS FOR THE PREVENTION OF CARDIOVASCULAR DISEASE AND DIABETES INCIDENCE--THE BENEFITS VERSUS THE RISKS].
Lavie G; Cohen S
Harefuah; 2015 Jun; 154(6):382-6, 404. PubMed ID: 26281083
[TBL] [Abstract][Full Text] [Related]
13. Use of statins and the incidence of type 2 diabetes mellitus.
Bernardi A; Rocha VZ; Faria-Neto JR
Rev Assoc Med Bras (1992); 2015 Aug; 61(4):375-80. PubMed ID: 26466221
[TBL] [Abstract][Full Text] [Related]
14. Statin therapy and related risk of new-onset type 2 diabetes mellitus.
Ruscica M; Macchi C; Morlotti B; Sirtori CR; Magni P
Eur J Intern Med; 2014 Jun; 25(5):401-6. PubMed ID: 24685426
[TBL] [Abstract][Full Text] [Related]
15. Statin treatment and new-onset diabetes: a review of proposed mechanisms.
Brault M; Ray J; Gomez YH; Mantzoros CS; Daskalopoulou SS
Metabolism; 2014 Jun; 63(6):735-45. PubMed ID: 24641882
[TBL] [Abstract][Full Text] [Related]
16. Statin treatment and increased diabetes risk. Possible mechanisms.
Climent E; Benaiges D; Pedro-Botet J
Clin Investig Arterioscler; 2019; 31(5):228-232. PubMed ID: 30737072
[TBL] [Abstract][Full Text] [Related]
17. HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis.
Palmer SC; Navaneethan SD; Craig JC; Johnson DW; Perkovic V; Hegbrant J; Strippoli GF
Cochrane Database Syst Rev; 2014 May; (5):CD007784. PubMed ID: 24880031
[TBL] [Abstract][Full Text] [Related]
18. Putting the diabetes risk due to statins in perspective: a re-evaluation using the complementary outcome.
Furuya-Kanamori L; Stone JC; Doi SA
Nutr Metab Cardiovasc Dis; 2014 Jul; 24(7):705-8. PubMed ID: 24780516
[TBL] [Abstract][Full Text] [Related]
19. The diabetogenic action of statins - mechanisms and clinical implications.
Betteridge DJ; Carmena R
Nat Rev Endocrinol; 2016 Feb; 12(2):99-110. PubMed ID: 26668119
[TBL] [Abstract][Full Text] [Related]
20. Statins and diabetes risk: how real is it and what are the mechanisms?
Robinson JG
Curr Opin Lipidol; 2015 Jun; 26(3):228-35. PubMed ID: 25887679
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
